South Carolina DHEC now requires all long-term care (LTC) pharmacies to report dispensed controlled substances to the state's Prescription Monitoring Program (SC PMP). The department wants compliance by the end of the month, and it is in the process of notifying pharmacies.
News: Prescription Monitoring Programs
Effective January 4, 2019, the Michigan Automated Prescription System (MAPS) for the reporting of controlled substances made gabapentin a Schedule V controlled substance. Pharmacies have 7 days to comply, which is Friday, January 11.
Effective January 1, 2019, the Tennessee Prescription Monitoring Program (TN PMP) requires reporting of the Treatment Type and ICD-10 Diagnosis Code.
Effective December 4, 2018, the Minnesota Prescription Monitoring Program (MN PMP) moved controlled substance reporting to the Appriss® PMP Clearinghouse.
Pursuant to new legislation effective July 1, 2018, the Virginia Department of Health Professions prescription monitoring program (VA PMP) will now monitor the prescribing and dispensing of Schedule V drugs and naloxone.
Effective July 1, 2018, the Alaska Prescription Drug Monitoring Program (AK PDMP) will begin requiring dispensers to report controlled substance dispensations to the AK PDMP daily as of the previous submission date, as required in AS 17.30.200 and 12 AAC 52.865(b).
Effective July 1, 2018, the Maine Prescription Monitoring Program (ME PMP) requires reporting in ASAP 4.2A Standard and includes the following important changes.